AbbVie, Ironwood constipation therapy Linzess meets main goal of phase 3 trial in children
AbbVie (ABBV) and Ironwood Pharmaceuticals'' medicine (IRWD) Linzess met the main and secondary goals of a phase 3 trial in pediatric patients aged six years to 17 years with…
AbbVie, Ironwood constipation therapy Linzess meets main goal of phase 3 trial in children
AbbVie (ABBV) and Ironwood Pharmaceuticals'' medicine (IRWD) Linzess met the main and secondary goals of a phase 3 trial in pediatric patients aged six years to 17 years with…